0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Torasemide API Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-37B11450
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Torasemide API Market Research Report 2022

Global Torasemide API Market Research Report 2022

Code: QYRE-Auto-37B11450
Report
August 2022
96 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Highlights

The global Torasemide API market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Torasemide API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Torasemide API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global companies of Torasemide API include Zhejiang Huahai Pharmaceutical, Hubei Biocause Heilen Pharmaceutical, Nuray Chemicals, Zeon Health Industries, Teva API, Apotex Pharmachem, Aspire Lifesciences, Aurobindo Pharma and Boryung Pharmaceutical, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Torasemide API in Injections is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, 0.98, which accounted for % of the global market of Torasemide API in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Torasemide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Torasemide API.
The Torasemide API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Torasemide API market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Torasemide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Zhejiang Huahai Pharmaceutical
Hubei Biocause Heilen Pharmaceutical
Nuray Chemicals
Zeon Health Industries
Teva API
Apotex Pharmachem
Aspire Lifesciences
Aurobindo Pharma
Boryung Pharmaceutical
JARI Pharmaceutical
Kalintis Healthcare
Sanochemia Pharmazeutika GmbH
Vaishali Pharma
Product Type Insights
Global markets are presented by Torasemide API purity, along with growth forecasts through 2028. Estimates on production and value are based on the price in the supply chain at which the Torasemide API are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Torasemide API segment by Purity
0.98
0.99
Others
Application Insights
This report has provided the market size (production and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Torasemide API market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Torasemide API market.

Torasemide API segment by Application

Injections
Tablets
Capsules
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast value for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Torasemide API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Torasemide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Torasemide API and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Torasemide API industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Torasemide API.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Torasemide API manufacturers competitive landscape, price, output and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Torasemide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Torasemide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 5: Provides the analysis of various market segments according to product purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, revenue, , price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Analysis of sales channel, distributors and customers
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: Production and supply forecast, global and regional
Chapter 12: Consumption and demand forecast, global and regional
Chapter 13: Forecast by purity and by application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 14: The main points and conclusions of the report.
1 Torasemide API Market Overview
1.1 Product Overview and Scope of Torasemide API
1.2 Torasemide API Segment by Purity
1.2.1 Global Torasemide API Market Size Growth Rate Analysis by Purity 2022 VS 2028
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Torasemide API Segment by Application
1.3.1 Global Torasemide API Consumption Comparison by Application: 2022 VS 2028
1.3.2 Injections
1.3.3 Tablets
1.3.4 Capsules
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Torasemide API Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Torasemide API Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Torasemide API Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Torasemide API Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Torasemide API Estimates and Forecasts (2017-2028)
1.5.3 Europe Torasemide API Estimates and Forecasts (2017-2028)
1.5.4 China Torasemide API Estimates and Forecasts (2017-2028)
1.5.5 Japan Torasemide API Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Torasemide API Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Torasemide API Revenue Market Share by Manufacturers (2017-2022)
2.3 Torasemide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Torasemide API Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Torasemide API Production Sites, Area Served, Product Types
2.6 Torasemide API Market Competitive Situation and Trends
2.6.1 Torasemide API Market Concentration Rate
2.6.2 Global 5 and 10 Largest Torasemide API Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Torasemide API Market Share by Region (2017-2022)
3.2 Global Torasemide API Revenue Market Share by Region (2017-2022)
3.3 Global Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Torasemide API Production
3.4.1 North America Torasemide API Production Growth Rate (2017-2022)
3.4.2 North America Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Torasemide API Production
3.5.1 Europe Torasemide API Production Growth Rate (2017-2022)
3.5.2 Europe Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Torasemide API Production
3.6.1 China Torasemide API Production Growth Rate (2017-2022)
3.6.2 China Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Japan Torasemide API Production
3.7.1 Japan Torasemide API Production Growth Rate (2017-2022)
3.7.2 Japan Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Torasemide API Consumption by Region
4.1 Global Torasemide API Consumption by Region
4.1.1 Global Torasemide API Consumption by Region
4.1.2 Global Torasemide API Consumption Market Share by Region
4.2 North America
4.2.1 North America Torasemide API Consumption by Country
4.2.2 United States
4.2.3 Canada
4.3 Europe
4.3.1 Europe Torasemide API Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Torasemide API Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Torasemide API Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Purity
5.1 Global Torasemide API Production Market Share by Purity (2017-2022)
5.2 Global Torasemide API Revenue Market Share by Purity (2017-2022)
5.3 Global Torasemide API Price by Purity (2017-2022)
6 Segment by Application
6.1 Global Torasemide API Production Market Share by Application (2017-2022)
6.2 Global Torasemide API Revenue Market Share by Application (2017-2022)
6.3 Global Torasemide API Price by Application (2017-2022)
7 Key Companies Profiled
7.1 Zhejiang Huahai Pharmaceutical
7.1.1 Zhejiang Huahai Pharmaceutical Torasemide API Corporation Information
7.1.2 Zhejiang Huahai Pharmaceutical Torasemide API Product Portfolio
7.1.3 Zhejiang Huahai Pharmaceutical Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.1.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.2 Hubei Biocause Heilen Pharmaceutical
7.2.1 Hubei Biocause Heilen Pharmaceutical Torasemide API Corporation Information
7.2.2 Hubei Biocause Heilen Pharmaceutical Torasemide API Product Portfolio
7.2.3 Hubei Biocause Heilen Pharmaceutical Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.2.4 Hubei Biocause Heilen Pharmaceutical Main Business and Markets Served
7.2.5 Hubei Biocause Heilen Pharmaceutical Recent Developments/Updates
7.3 Nuray Chemicals
7.3.1 Nuray Chemicals Torasemide API Corporation Information
7.3.2 Nuray Chemicals Torasemide API Product Portfolio
7.3.3 Nuray Chemicals Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.3.4 Nuray Chemicals Main Business and Markets Served
7.3.5 Nuray Chemicals Recent Developments/Updates
7.4 Zeon Health Industries
7.4.1 Zeon Health Industries Torasemide API Corporation Information
7.4.2 Zeon Health Industries Torasemide API Product Portfolio
7.4.3 Zeon Health Industries Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.4.4 Zeon Health Industries Main Business and Markets Served
7.4.5 Zeon Health Industries Recent Developments/Updates
7.5 Teva API
7.5.1 Teva API Torasemide API Corporation Information
7.5.2 Teva API Torasemide API Product Portfolio
7.5.3 Teva API Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.5.4 Teva API Main Business and Markets Served
7.5.5 Teva API Recent Developments/Updates
7.6 Apotex Pharmachem
7.6.1 Apotex Pharmachem Torasemide API Corporation Information
7.6.2 Apotex Pharmachem Torasemide API Product Portfolio
7.6.3 Apotex Pharmachem Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.6.4 Apotex Pharmachem Main Business and Markets Served
7.6.5 Apotex Pharmachem Recent Developments/Updates
7.7 Aspire Lifesciences
7.7.1 Aspire Lifesciences Torasemide API Corporation Information
7.7.2 Aspire Lifesciences Torasemide API Product Portfolio
7.7.3 Aspire Lifesciences Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.7.4 Aspire Lifesciences Main Business and Markets Served
7.7.5 Aspire Lifesciences Recent Developments/Updates
7.8 Aurobindo Pharma
7.8.1 Aurobindo Pharma Torasemide API Corporation Information
7.8.2 Aurobindo Pharma Torasemide API Product Portfolio
7.8.3 Aurobindo Pharma Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.8.4 Aurobindo Pharma Main Business and Markets Served
7.7.5 Aurobindo Pharma Recent Developments/Updates
7.9 Boryung Pharmaceutical
7.9.1 Boryung Pharmaceutical Torasemide API Corporation Information
7.9.2 Boryung Pharmaceutical Torasemide API Product Portfolio
7.9.3 Boryung Pharmaceutical Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.9.4 Boryung Pharmaceutical Main Business and Markets Served
7.9.5 Boryung Pharmaceutical Recent Developments/Updates
7.10 JARI Pharmaceutical
7.10.1 JARI Pharmaceutical Torasemide API Corporation Information
7.10.2 JARI Pharmaceutical Torasemide API Product Portfolio
7.10.3 JARI Pharmaceutical Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.10.4 JARI Pharmaceutical Main Business and Markets Served
7.10.5 JARI Pharmaceutical Recent Developments/Updates
7.11 Kalintis Healthcare
7.11.1 Kalintis Healthcare Torasemide API Corporation Information
7.11.2 Kalintis Healthcare Torasemide API Product Portfolio
7.11.3 Kalintis Healthcare Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.11.4 Kalintis Healthcare Main Business and Markets Served
7.11.5 Kalintis Healthcare Recent Developments/Updates
7.12 Sanochemia Pharmazeutika GmbH
7.12.1 Sanochemia Pharmazeutika GmbH Torasemide API Corporation Information
7.12.2 Sanochemia Pharmazeutika GmbH Torasemide API Product Portfolio
7.12.3 Sanochemia Pharmazeutika GmbH Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.12.4 Sanochemia Pharmazeutika GmbH Main Business and Markets Served
7.12.5 Sanochemia Pharmazeutika GmbH Recent Developments/Updates
7.13 Vaishali Pharma
7.13.1 Vaishali Pharma Torasemide API Corporation Information
7.13.2 Vaishali Pharma Torasemide API Product Portfolio
7.13.3 Vaishali Pharma Torasemide API Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.13.4 Vaishali Pharma Main Business and Markets Served
7.13.5 Vaishali Pharma Recent Developments/Updates
8 Torasemide API Manufacturing Cost Analysis
8.1 Torasemide API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Torasemide API
8.4 Torasemide API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Torasemide API Distributors List
9.3 Torasemide API Customers
10 Market Dynamics
10.1 Torasemide API Industry Trends
10.2 Torasemide API Market Drivers
10.3 Torasemide API Market Challenges
10.4 Torasemide API Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Torasemide API by Region (2023-2028)
11.2 North America Torasemide API Production, Revenue Forecast (2023-2028)
11.3 Europe Torasemide API Production, Revenue Forecast (2023-2028)
11.4 China Torasemide API Production, Revenue Forecast (2023-2028)
11.5 Japan Torasemide API Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Torasemide API
12.2 North America Forecasted Consumption of Torasemide API by Country
12.3 Europe Market Forecasted Consumption of Torasemide API by Country
12.4 Asia Pacific Market Forecasted Consumption of Torasemide API by Region
12.5 Latin America Forecasted Consumption of Torasemide API by Country
13 Forecast by Purity and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Purity (2023-2028)
13.1.1 Global Forecasted Production of Torasemide API by Purity (2023-2028)
13.1.2 Global Forecasted Revenue of Torasemide API by Purity (2023-2028)
13.1.3 Global Forecasted Price of Torasemide API by Purity (2023-2028)
13.2 Global Forecasted Consumption of Torasemide API by Application (2023-2028)
13.2.1 Global Forecasted Production of Torasemide API by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Torasemide API by Application (2023-2028)
13.2.3 Global Forecasted Price of Torasemide API by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
    Table 1. Global Torasemide API Market Size by Purity (Tons) & (US$ Million) (2022 VS 2028)
    Table 2. Global Torasemide API Market Size by Application (Tons) & (US$ Million) (2022 VS 2028)
    Table 3. Torasemide API Market Size Comparison by Region: 2017 VS 2021 VS 2028
    Table 4. Global Torasemide API Production Capacity by Manufacturers (2017-2022) & (Tons)
    Table 5. Global Torasemide API Production (Tons) by Manufacturers (2017-2022)
    Table 6. Global Torasemide API Production Market Share by Manufacturers (2017-2022)
    Table 7. Global Torasemide API Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 8. Global Torasemide API Revenue Share by Manufacturers (2017-2022)
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Torasemide API as of 2021)
    Table 10. Global Market Torasemide API Average Price (US$/Kg) of Key Manufacturers (2017-2022)
    Table 11. Manufacturers Torasemide API Production Sites and Area Served
    Table 12. Manufacturers Torasemide API Product Types
    Table 13. Global Torasemide API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Torasemide API Production Capacity (Tons) by Region (2017-2022)
    Table 16. Global Torasemide API Production (Tons) by Region (2017-2022)
    Table 17. Global Torasemide API Revenue (US$ Million) by Region (2017-2022)
    Table 18. Global Torasemide API Revenue Market Share by Region (2017-2022)
    Table 19. Global Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 20. North America Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 21. Europe Torasemide API Production (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 22. China Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 23. Japan Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 24. Global Torasemide API Consumption Market by Region (2017-2022) & (Tons)
    Table 25. Global Torasemide API Consumption Market Share by Region (2017-2022)
    Table 26. North America Torasemide API Consumption by Country (2017-2022) & (Tons)
    Table 27. Europe Torasemide API Consumption by Country (2017-2022) & (Tons)
    Table 28. Asia Pacific Torasemide API Consumption by Region (2017-2022) & (Tons)
    Table 29. Latin America Torasemide API Consumption by Country (2017-2022) & (Tons)
    Table 30. Global Torasemide API Production (Tons) by Purity (2017-2022)
    Table 31. Global Torasemide API Production Market Share by Purity (2017-2022)
    Table 32. Global Torasemide API Revenue (US$ Million) by Purity (2017-2022)
    Table 33. Global Torasemide API Revenue Share by Purity (2017-2022)
    Table 34. Global Torasemide API Price (US$/Kg) by Purity (2017-2022)
    Table 35. Global Torasemide API Production by Application (2017-2022) & (Tons)
    Table 36. Global Torasemide API Production Market Share by Application (2017-2022)
    Table 37. Global Torasemide API Revenue (US$ Million) by Application (2017-2022)
    Table 38. Global Torasemide API Revenue Share by Application (2017-2022)
    Table 39. Global Torasemide API Price (US$/Kg) by Application (2017-2022)
    Table 40. Zhejiang Huahai Pharmaceutical Torasemide API Corporation Information
    Table 41. Zhejiang Huahai Pharmaceutical Specification and Application
    Table 42. Zhejiang Huahai Pharmaceutical Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 43. Zhejiang Huahai Pharmaceutical Main Business and Markets Served
    Table 44. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
    Table 45. Hubei Biocause Heilen Pharmaceutical Torasemide API Corporation Information
    Table 46. Hubei Biocause Heilen Pharmaceutical Specification and Application
    Table 47. Hubei Biocause Heilen Pharmaceutical Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 48. Hubei Biocause Heilen Pharmaceutical Main Business and Markets Served
    Table 49. Hubei Biocause Heilen Pharmaceutical Recent Developments/Updates
    Table 50. Nuray Chemicals Torasemide API Corporation Information
    Table 51. Nuray Chemicals Specification and Application
    Table 52. Nuray Chemicals Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 53. Nuray Chemicals Main Business and Markets Served
    Table 54. Nuray Chemicals Recent Developments/Updates
    Table 55. Zeon Health Industries Torasemide API Corporation Information
    Table 56. Zeon Health Industries Specification and Application
    Table 57. Zeon Health Industries Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 58. Zeon Health Industries Main Business and Markets Served
    Table 59. Zeon Health Industries Recent Developments/Updates
    Table 60. Teva API Torasemide API Corporation Information
    Table 61. Teva API Specification and Application
    Table 62. Teva API Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 63. Teva API Main Business and Markets Served
    Table 64. Teva API Recent Developments/Updates
    Table 65. Apotex Pharmachem Torasemide API Corporation Information
    Table 66. Apotex Pharmachem Specification and Application
    Table 67. Apotex Pharmachem Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 68. Apotex Pharmachem Main Business and Markets Served
    Table 69. Apotex Pharmachem Recent Developments/Updates
    Table 70. Aspire Lifesciences Torasemide API Corporation Information
    Table 71. Aspire Lifesciences Specification and Application
    Table 72. Aspire Lifesciences Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 73. Aspire Lifesciences Main Business and Markets Served
    Table 74. Aspire Lifesciences Recent Developments/Updates
    Table 75. Aurobindo Pharma Torasemide API Corporation Information
    Table 76. Aurobindo Pharma Specification and Application
    Table 77. Aurobindo Pharma Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 78. Aurobindo Pharma Main Business and Markets Served
    Table 79. Aurobindo Pharma Recent Developments/Updates
    Table 80. Boryung Pharmaceutical Torasemide API Corporation Information
    Table 81. Boryung Pharmaceutical Specification and Application
    Table 82. Boryung Pharmaceutical Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 83. Boryung Pharmaceutical Main Business and Markets Served
    Table 84. Boryung Pharmaceutical Recent Developments/Updates
    Table 85. JARI Pharmaceutical Torasemide API Corporation Information
    Table 86. JARI Pharmaceutical Specification and Application
    Table 87. JARI Pharmaceutical Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 88. JARI Pharmaceutical Main Business and Markets Served
    Table 89. JARI Pharmaceutical Recent Developments/Updates
    Table 90. Kalintis Healthcare Torasemide API Corporation Information
    Table 91. Kalintis Healthcare Specification and Application
    Table 92. Kalintis Healthcare Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 93. Kalintis Healthcare Main Business and Markets Served
    Table 94. Kalintis Healthcare Recent Developments/Updates
    Table 95. Sanochemia Pharmazeutika GmbH Torasemide API Corporation Information
    Table 96. Sanochemia Pharmazeutika GmbH Specification and Application
    Table 97. Sanochemia Pharmazeutika GmbH Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 98. Sanochemia Pharmazeutika GmbH Main Business and Markets Served
    Table 99. Sanochemia Pharmazeutika GmbH Recent Developments/Updates
    Table 100. Vaishali Pharma Torasemide API Corporation Information
    Table 101. Vaishali Pharma Specification and Application
    Table 102. Vaishali Pharma Torasemide API Production Capacity (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 103. Vaishali Pharma Main Business and Markets Served
    Table 104. Vaishali Pharma Recent Developments/Updates
    Table 105. Production Base and Market Concentration Rate of Raw Material
    Table 106. Key Suppliers of Raw Materials
    Table 107. Torasemide API Distributors List
    Table 108. Torasemide API Customers List
    Table 109. Torasemide API Market Trends
    Table 110. Torasemide API Market Drivers
    Table 111. Torasemide API Market Challenges
    Table 112. Torasemide API Market Restraints
    Table 113. Global Torasemide API Production (Tons) Forecast by Region (2023-2028)
    Table 114. North America Torasemide API Consumption Forecast by Country (2023-2028) & (Tons)
    Table 115. Europe Torasemide API Consumption Forecast by Country (2023-2028) & (Tons)
    Table 116. Asia Pacific Torasemide API Consumption Forecast by Region (2023-2028) & (Tons)
    Table 117. Latin America Torasemide API Consumption Forecast by Country (2023-2028) & (Tons)
    Table 118. Global Torasemide API Production Forecast by Purity (2023-2028) & (Tons)
    Table 119. Global Torasemide API Revenue Forecast by Purity (2023-2028) & (US$ Million)
    Table 120. Global Torasemide API Price Forecast by Purity (2023-2028) & (US$/Kg)
    Table 121. Global Torasemide API Production Forecast by Application (2023-2028) & (Tons)
    Table 122. Global Torasemide API Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 123. Global Torasemide API Price Forecast by Application (2023-2028) & (US$/Kg)
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Torasemide API
    Figure 2. Global Torasemide API Market Share by Purity: 2022 VS 2028
    Figure 3. 0.98 Product Picture
    Figure 4. 0.99 Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Torasemide API Market Share by Application: 2022 VS 2028
    Figure 7. Injections
    Figure 8. Tablets
    Figure 9. Capsules
    Figure 10. Others
    Figure 11. Global Torasemide API Revenue (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Torasemide API Revenue (US$ Million) (2017-2028)
    Figure 13. Global Torasemide API Production Capacity (Tons) & (2017-2028)
    Figure 14. Global Torasemide API Production (Tons) & (2017-2028)
    Figure 15. North America Torasemide API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 16. Europe Torasemide API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 17. China Torasemide API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 18. Japan Torasemide API Revenue (US$ Million) and Growth Rate (2017-2028)
    Figure 19. Torasemide API Production Share by Manufacturers in 2021
    Figure 20. Global Torasemide API Revenue Share by Manufacturers in 2021
    Figure 21. Torasemide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Market Torasemide API Average Price (US$/Kg) of Key Manufacturers in 2021
    Figure 23. The Global 5 and 10 Largest Players: Market Share by Torasemide API Revenue in 2021
    Figure 24. Global Torasemide API Production Market Share by Region (2017-2022)
    Figure 25. North America Torasemide API Production (Tons) Growth Rate (2017-2022)
    Figure 26. Europe Torasemide API Production (Tons) Growth Rate (2017-2022)
    Figure 27. China Torasemide API Production (Tons) Growth Rate (2017-2022)
    Figure 28. Japan Torasemide API Production (Tons) Growth Rate (2017-2022)
    Figure 29. Global Torasemide API Consumption Market Share by Region (2017-2022)
    Figure 30. North America Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 31. North America Torasemide API Consumption Market Share by Country in 2021
    Figure 32. Canada Torasemide API Consumption Growth Rate (2017-2022) & (Tons)
    Figure 33. U.S. Torasemide API Consumption Growth Rate (2017-2022) & (Tons)
    Figure 34. Europe Torasemide API Consumption Growth Rate (2017-2022) & (Tons)
    Figure 35. Europe Torasemide API Consumption Market Share by Country in 2021
    Figure 36. Germany Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 37. France Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 38. U.K. Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 39. Italy Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 40. Russia Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 41. Asia Pacific Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 42. Asia Pacific Torasemide API Consumption Market Share by Regions in 2021
    Figure 43. China Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 44. Japan Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 45. South Korea Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 46. China Taiwan Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 47. Southeast Asia Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 48. India Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 49. Australia Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 50. Latin America Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 51. Latin America Torasemide API Consumption Market Share by Country in 2021
    Figure 52. Mexico Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 53. Brazil Torasemide API Consumption and Growth Rate (2017-2022) & (Tons)
    Figure 54. Production Market Share of Torasemide API by Purity (2017-2022)
    Figure 55. Production Market Share of Torasemide API by Purity in 2021
    Figure 56. Revenue Share of Torasemide API by Purity (2017-2022)
    Figure 57. Revenue Market Share of Torasemide API by Purity in 2021
    Figure 58. Production Market Share of Torasemide API by Application (2017-2022)
    Figure 59. Production Market Share of Torasemide API by Application in 2021
    Figure 60. Revenue Share of Torasemide API by Application (2017-2022)
    Figure 61. Revenue Market Share of Torasemide API by Application in 2021
    Figure 62. Manufacturing Cost Structure of Torasemide API
    Figure 63. Manufacturing Process Analysis of Torasemide API
    Figure 64. Torasemide API Industrial Chain Analysis
    Figure 65. Channels of Distribution
    Figure 66. Distributors Profiles
    Figure 67. Global Torasemide API Production Market Share Forecast by Region (2023-2028)
    Figure 68. North America Torasemide API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 69. Europe Torasemide API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 70. China Torasemide API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 71. Japan Torasemide API Production (Tons) Growth Rate Forecast (2023-2028)
    Figure 72. Global Forecasted Demand Analysis of Torasemide API (2017-2028) & (Tons)
    Figure 73. Global Torasemide API Production Market Share Forecast by Purity (2023-2028)
    Figure 74. Global Torasemide API Revenue Market Share Forecast by Purity (2023-2028)
    Figure 75. Global Torasemide API Production Market Share Forecast by Application (2023-2028)
    Figure 76. Global Torasemide API Revenue Market Share Forecast by Application (2023-2028)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools
SIMILAR REPORTS